Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins

Slides:

Advertisements

Similar presentations

Differential Response to Preoperative Chemoradiation and Surgery in Esophageal Adenocarcinomas Based on Presence of Barrett's Esophagus and Symptomatic.

Advertisements

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution Linda W. Martin, MD, Arlene.

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma Kimberly S. Grant, MD,

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Stephen R. Broderick, MD, MPHS

Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer Stephen G. Swisher, MD, Mary Maish, MD, Jeremy J. Erasmus, MD, Arlene.

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Arjun Pennathur, MD, Liqiang Xi, MD, Virginia R. Litle, MD, William E

Puja Gaur, MD, Wayne L. Hofstetter, MD, B

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population Edmund S. Kassis, MD, Ara A. Vaporciyan,

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy Apar Pataer, MD, PhD, Neda Kalhor,

Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

David C. Rice, MB, BCh, Matthew A

William M. DeCampli, MD, PhD

Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective.

It is still mostly about the mitral valve

Anthony J. Ascioti, MD, Wayne L. Hofstetter, MD, Michael J

Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System Wayne Hofstetter, MD, Arlene M. Correa, PhD, Neby Bekele, PhD, Jaffer A.

Bigger The Journal of Thoracic and Cardiovascular Surgery

The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy Arya Amini, BA, Arlene.

The lord of the rings Antonio Miceli, MD, PhD

Dhakshina Moorthy Ganeshan, MD, Arlene M

Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma David C. Rice, MB, BCh, Craig.

Yang Zhang, MD, Haiquan Chen, MD, PhD

Support Your Specialty

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

A first start for lung transplantation?

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response.

Stephen R. Broderick, MD, MPHS

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon

Instrumental variable methods in clinical research

A fate worse than death Jennifer S. Lawton, MD

Attachment disorder in thoracoabdominal surgery

Pathologic complete response after esophagectomy following neoadjuvant chemoradiation therapy for esophageal carcinoma: A cure sometimes? Shawn S. Groth,

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer Stephen G. Swisher, MDa, Linda DeFord, MSb, Kelly.

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma Kimberly S. Grant, MD,

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD,

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

James I. Fann, MD, John E. Connolly, MD

Mara B. Antonoff, MD, Wayne L. Hofstetter, MD, Arlene M

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Surgical outcomes after cardiac surgery in liver transplant recipients

Bicuspid aortopathy: Seeing the forest for the trees

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

“The more things change…”: The challenges ahead

More than vital: Who bears the burden?

Did you like Terminator 3 better than Terminator 2

How do we follow up our patients

Journal changes and initiatives

A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for.

Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer Stephen G. Swisher, MD, Wayne Hofstetter, MD, Ritsuko Komaki, MD, Arlene.

Jenifer L. Marks, MD, Wayne Hofstetter, MD, Arlene M

Calpain inhibitors: The aspirin of the 21st century?

Presentation transcript:

Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins John A. Harvin, MD, Guy Lahat, MD, Arlene M. Correa, PhD, Jared Lee, MS, Dipen Maru, MD, Jaffer Ajani, MD, Edith M. Marom, MD, James Welsh, MD, Manoop S. Bhutani, MD, Garret Walsh, MD, Jack Roth, MD, Reza Mehran, MD, Ara Vaporciyan, MD, David Rice, MD, Stephen Swisher, MD, Wayne Hofstetter, MD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 2, Pages 412-420 (February 2012) DOI: 10.1016/j.jtcvs.2011.10.044 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Kaplan-Meier curves for outcomes of cohort according to Royal College of Pathologists (RCP) criteria. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 412-420DOI: (10.1016/j.jtcvs.2011.10.044) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Kaplan-Meier curves for outcomes of cohort according to College of American Pathologists (CAP) criteria by log-rank test and propensity score match. LR, Log rank; PSM, propensity score matching. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 412-420DOI: (10.1016/j.jtcvs.2011.10.044) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions